---
author: []
related: []
publisher:
  url: 'http://www.cannabisbusinesstimes.com'
  name: Cannabis Business Times
  favicon: >-
    http://www.cannabisbusinesstimes.com/fileuploads/image/logos/favicons/cbt.png
  domain: www.cannabisbusinesstimes.com
keywords:
  - marijuana
  - dea
  - cannabis
  - research
  - research-grade
  - medical
  - manufacturers
  - schedule
  - drug
  - rescheduling
description: >-
  The U.S. Drug Enforcement Agency denied two petitions to reschedule cannabis
  from Schedule I, according to an announcement released by the organization
  Aug. 11. This denial means maintaining the DEA's current stance that marijuana
  has no medical value. The DEA also increased the number of registered
  manufacturers supplying marijuana for research.
inLanguage: en
app_links: []
isBasedOnUrl: >-
  http://www.cannabisbusinesstimes.com/article/081116-dea-denies-cannabis-reschedule/
title: >-
  DEA Denies Cannabis Rescheduling, Expands Research Policies - Cannabis
  Business Times
datePublished: '2016-08-11T16:43:16.884Z'
dateModified: '2016-08-11T16:42:57.751Z'
via: {}
starred: false
sourcePath: >-
  _posts/2016-08-11-dea-denies-cannabis-rescheduling-expands-research-policies.md
inFeed: true
hasPage: false
inNav: false
_context: 'http://schema.org'
_type: MediaObject

---
<article style=""><h1>DEA Denies Cannabis Rescheduling, Expands Research Policies - Cannabis Business Times</h1><p>The U.S. Drug Enforcement Agency denied two petitions to reschedule cannabis from Schedule I, according to an announcement released by the organization Aug. 11. This denial means maintaining the DEA's current stance that marijuana has no medical value. The DEA also increased the number of registered manufacturers supplying marijuana for research.</p><img src="http://www.cannabisbusinesstimes.com/FileUploads/image/DEA-08112016.jpg?w=736&amp;h=414&amp;mode=crop" /></article>